A year later: What we know about SARS-CoV-2 infectivity and growing concerns of emerging variants
A summary of SARS-CoV-2 cell entry mechanisms
ACRO providing PATH, a non-profit global health organization, with materials to support the development of high quality COVID-19 diagnostics
Neutralizing Antibodies in the Fight against COVID-19
ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.
The newly launched PE-labeled SLAMF7 protein is a powerful tool for detecting anti-SLAMF7 CAR expression by one step staining with high sensitivity and high specificity. FITC and Biotin-labeled SLAMF7 proteins are also available.
This web search service is supported by Google Inc.